Noul
IPOBeyond Diagnostics
About
Noul develops decentralized diagnostic solutions for blood and tissue testing. Its miLab platform digitizes the testing workflow through staining, scanning, and AI analysis, and is designed to improve access to rapid, accurate diagnostics. The company focuses on serious unmet global health problems, including blood-cell analysis and cancer diagnostics, and operates from its Korean headquarters while collaborating with international research and health organizations.
Summary
Noul is a Biotech company based in Yongin, South Korea. Its most recent funding was a Grant round in Mar 2023.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2023
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/noul"><img src="https://indexed.vc/api/badge/company/noul" alt="Noul on Indexed.vc" width="260" height="76" /></a>